Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient.
about
Management of psoriasis patients with hepatitis B or hepatitis C virus infectionHepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasisHepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.Emerging challenges in managing hepatitis B in HIV patients.Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases.Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.The role of IL-12/23 in T cell-related chronic inflammation: implications of immunodeficiency and therapeutic blockade.Biologics in dermatology: adverse effects.The use of ustekinumab in a patient with severe psoriasis and positive HBV serology.Latent virus reactivation risk and biological drugs: chronic inflammatory and immune-mediated disorders.Editorial: Leukocytes in tularemia--so many cells, so little time.The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and C.
P2860
Q28078157-2B4EAA78-9FD7-4FA1-A7B8-8BBA7A330670Q33654733-8DF3D62C-D428-4685-BDE7-5368741EC239Q33800651-E80A2226-9188-4D7B-B7C3-E804F47AE40CQ34786720-8A3E8670-8D8F-4B73-84C4-03CE384B3E23Q35567748-0F47AAC2-5581-4B67-B459-D91485378704Q38408897-28959C57-9194-423B-B3F0-9CB7C2E184FAQ38544189-4CF5F8EE-9B29-40A2-B73D-84B74FD7357FQ38634826-0BF8648E-F68A-4568-A510-A79B333FCBEFQ38749257-B9230D3F-BEDE-447B-8E87-A36F1CF91E6CQ38755178-FBF7361B-9487-46BB-BC14-10E12425F6A0Q39328684-B7334FA1-CE12-4C00-9FC2-C57F2334047FQ41120913-5AAFB717-C28B-44E2-BB28-804B8B3745B9Q42204345-8DAEA74F-77B9-4B7E-BCC2-A83EB4FE8EC0Q42236159-6A5F4694-1FFE-4EE5-82CD-BBADB1068E52Q43192563-6BC04F48-8EE6-4EC6-A1BD-5CFF157FD4ABQ44509047-D6FBE4BC-A1A7-4C05-92AB-E4CD7928DEA1Q45017976-A02066B0-05C1-4FD3-B604-1A06DC10F727
P2860
Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Hepatitis B virus reactivation ...... ive anti-HBs-positive patient.
@en
Hepatitis B virus reactivation ...... ive anti-HBs-positive patient.
@nl
type
label
Hepatitis B virus reactivation ...... ive anti-HBs-positive patient.
@en
Hepatitis B virus reactivation ...... ive anti-HBs-positive patient.
@nl
prefLabel
Hepatitis B virus reactivation ...... ive anti-HBs-positive patient.
@en
Hepatitis B virus reactivation ...... ive anti-HBs-positive patient.
@nl
P2093
P2860
P356
P1476
Hepatitis B virus reactivation ...... ive anti-HBs-positive patient.
@en
P2093
P2860
P304
P356
10.1111/BJD.12120
P407
P577
2013-01-31T00:00:00Z